UBS upgraded Givaudan to Neutral from Sell with a price target of CHF 3,900, up from CHF 3,200. While the stock’s valuation multiple remains high relative to the historical average, upside to consensus estimates limits the downside risk, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GVDNY:
